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Abstract
Purpose: The 3 carotenoids lutein, zeaxanthin, and meso zeaxanthin, which account for the ‘yellow spot’ at the macula and which are referred to as macular pigment (MP), are
believed to play a role in visual function and protect against
age-related macular degeneration (AMD) via their optical
and antioxidant properties. This study was undertaken to
compare MP optical density (MPOD) in a population aged
150 years with MPOD values from a normative database of
subjects aged 18–60 years. Methods: Seventy-nine subjects
were recruited into this pilot study (The Irish Longitudinal
Study on Ageing-TILDA). MPOD was measured using heterochromatic flicker photometry. Retinal fundus photographs,
lifestyle data and general health data, were also obtained.
Results: The mean 8 SD age of the 79 subjects recruited into
this study was 65 8 11 years. There was a moderate, but statistically significant, age-related decline in MPOD at 0.5° in
the TILDA data (r = –0.251, p = 0.045), which remained upon
merging with a normative database of an additional 462
subjects aged between 18 and 67 years (r = –0.179, p = 0.000).
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Conclusions: We report an inverse association between
MPOD and increasing age. Longitudinal data in a larger cohort of participants are required to satisfactorily investigate
the relationship between the optical density of this pigment
and age, and with risk for development and/or progression
of AMD. This pilot study represents a first step in this endeavour.
Copyright © 2010 S. Karger AG, Basel

Introduction

Age-related macular degeneration (AMD) is the advanced form of age-related maculopathy (ARM), and is
the leading cause of blindness in people over 50 years of
age in the developed world [1, 2]. The number of adults
registered blind as a result of AMD in industrialized
countries continues to rise, primarily due to increasing
longevity [3, 4]. Beyond its inevitable impact on the individual sufferer, AMD poses a growing socioeconomic
challenge to modern society [5–7].
Three dietary carotenoids, lutein, zeaxanthin and
meso-zeaxanthin, accumulate at the macula, where they
are collectively referred to as macular pigment (MP). Lutein and zeaxanthin are present in many foods, whereas
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meso-zeaxanthin is not found in a conventional diet, although it is found in certain types of seafood [8, 9]. In
recent years, the anatomic, biochemical and optical properties of MP have provoked interest in its putative protection for ARM [10].
The prevalence, incidence and progression of ARM
have been shown to rise exponentially with increasing
age [11, 12]. The free radical theory of ageing is consistent
with the notion that oxidative stress contributes to agerelated disorders, including ARM [10]. Given that MP is
an antioxidant present in the macula, and that ARM is an
age-related eye disease, MP’s association with age is of
particular interest.
To date, studies that have reported on the relationship
between age and MP have been inconsistent due to the differing methodologies used and differences in sample size
(table 1). However, the largest study to date to investigate
this relationship across an appropriate age distribution
(i.e. 20–60 years) has found a modest, but statistically significant, age-related decline in MP levels [13]; however, in
that study, the oldest subject recruited was 60 years of age.
The Irish Longitudinal Study on Ageing (TILDA) is a
prospective cohort study led by Trinity College Dublin
aimed at providing valid and reliable data relating to older people and ageing in Ireland. It will describe the social,
economic and health status of older Irish adults and try
to identify the factors that influence healthy ageing.
TILDA plans to recruit a nationally representative sample
of a minimum of 8,000 participants aged 50 years and
over, with detailed clinical assessments taking place in 3
waves. Interviews will take place on a 2-yearly basis with
a comprehensive health assessment at baseline and every
4 years thereafter.
The Macular Pigment Research Group (MPRG) at the
Waterford Institute of Technology (www.wit.ie/mprg) is
collaborating with TILDA, and has designed a study
which is primarily aimed at answering the following
question: does the amount of MP in an eye protect against
the commonest cause of blind registration in the western
world? To answer this question, we propose to measure
MP levels in TILDA participants at baseline, and again at
years 4 and 8, and correlate the findings with prevalence
and incidence of AMD. In this way, and uniquely, this
collaborative approach will be able to determine whether
baseline and serial MP levels relate to ultimate risk of developing AMD. Such a finding could possibly defer the
onset of the condition. Also, a finding that retinal nutritional status relates to the risk for developing AMD will
have major implications for health policy planners and
health care providers over the coming years.
2
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In this paper, we present baseline data from the TILDA
pilot study phase 1 population, thus allowing us to compare macular pigment optical density (MPOD) in a population aged 150 years with values from a normative database (subjects aged 18–60 years).

Methods
Subjects
The sample for this pilot study was selected using the updated
RANSAM sampling system developed by the Economic and Social Research Institute [14].
The sampling frame on which this system is based is the Irish
Geodirectory, a comprehensive and up-to-date listing and mapping of all residential addresses in the Republic of Ireland compiled by Ordnance Survey Ireland. The target area for the sample
comprised Dublin City and the county of Dun Laoghaire-Rathdown.
Addresses were randomly selected within this area by means
of a 3-stage process, incorporating proportionate stratification of
the primary sampling units (geographical units containing at
least 500 addresses) by socio-economic status (percent in professional/managerial occupations and per cent with third level education), age structure (percent of population aged 50 or over), and
geographical location. The sample is, therefore, a probability sample of addresses, where each address has a probability of selection
proportionate to the percentage of adults aged 50 or over in the
electoral division in which it is located.
Nineteen clusters of 40 addresses were selected, giving an initial sample of 760 addresses. Each address was visited by a fieldworker and one (randomly selected) household member aged 50
or over was selected as primary respondent for the survey. This
person’s spouse (of any age) was also selected for interview. A total
of 443 addresses were found to be ineligible (dwelling vacant or
did not contain a person aged 50 or over), leaving 317 valid addresses. Within these households, a total of 143 respondents completed an interview in their home. All 143 respondents were invited to attend Trinity College Dublin for a full health assessment,
of which, 79 accepted, and their data is presented in this paper.
This study was approved by the research ethics committee of
Trinity College Dublin, and subjects were required to sign an informed consent document prior to participation. All experimental procedures adhered to the tenets of the Declaration of Helsinki. Inclusion criteria for participation in this study were age 50
years or older, and being resident in the Republic of Ireland. Institutionalized people were excluded from recruitment.
Of particular interest to the macular assessment part of the
TILDA investigation, the following information was recorded for
each subject: demographic details; general health status and medication use; family history of AMD; personal smoking history.
The examination included: visual acuity (LogMAR); body mass
index [BMI (calculated as kg/m2)]; MPOD measurement by heterochromatic flicker photometry (HFP; using the Macular Metrics Densitometer TM, see below); undilated fundus photography,
using a non-mydriatic NIDEK NM100 Type D camera.
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Table 1. Previous studies which reported on the relationship between age and MP levels

Reference

Technique Test
stimulus

Parafoveal
Sample
stimuli
number
(eccentricity)

Age range,
years

Age effect

Correlation
coefficient

Werner, 1987 [$$]
Hammond, 2000 [22]
Ciulla, 2001 [21]
Delori, 2001 [$$]
Beatty, 2001 [37]
Mellerio, 2002 [23]
Nolan, 2004 [34]
Neelam, 2004 [$$]
Ciulla, 2004 [$$]
Bernstein, 2004 [$$]
Liew, 2005 [$$]
Trieschmann, 2006 [$$]
Nolan, 2007 [13]
Iannacone, 2007 [$$]
Richer, 2007 [$$]
Nolan, 2007 [29]
van der Veen, 2009 [$$]
Kilbride, 1989 [$$]
Delori, 2001 [$$]
Chen, 2001 [$$]
Berendschot, 2002 [$$]
Brockmans, 2002 [$$]
Wustemeyer, 2003 [$$]
Berendschot, 2004 [$$]
Zagers, 2004 [$$]
Berendschot, 2005 [25]
Berendschot, 2005 [25]
Berendschot, 2005 [25]
Berendschot, 2005 [25]
Berendschot, 2005 [25]
Delori, 2001 [$$]
Wustemeyer, 2003 [$$]
Liew, 2005 [$$]
Berendschot, 2005 [25]
Gellermann, 2002 [$$]
Bernstein, 2004 [$$]
Neelam, 2004 [$$]
Bone, 1998 [$$]
Handelman, 1998 [$$]
Bone, 2001 [$$]

HFP
HFP
HFP
HFP
HFP
HFP
HFP
HFP
HFP
HFP
HFP
AF
HFP
HFP
HFP
HFP
HFP
Ref.
Ref.
Ref.
Ref.
Ref.
Ref.
Ref.
Ref.
Ref.
Ref.
Ref.
Ref.
Ref.
AF
AF
AF
AF
RS
RS
RS
HPLC
HPLC
HPLC

5°
4°
4°
5.5°
6°
5°
5°
5°
4°
8°
5°
6°
5°
7°
7°
7°
8°

10–90
18–90
18–50
15–80
21–81
18–84
22–60
20–60
18–88
18–61
18–50
51–87
20–60
69–86
–
19–57
22–64
–
15–80
20–84
60–91
18–75
16–76
18–76
18–64
18–70
19–70
18–70
19–70
19–70
15–80
16–76
18–50
18–70
21–84
18–61
20–60
3–95
1 week to 81
58–98

decline
decline
none
none
decline
none
decline
decline
none
decline
none
decline
decline
decline
none
decline
increase
decline
increase
none
increase
none
decline
increase
none
none
increase
none
increase
decline
increase
none
increase
decline
decline
decline
decline
none
none
increase

–0.21
–0.14
–
–
–0.48
–0.06
–0.359
–0.181
0.04
–0.279
–
–
–0.286
–0.026
–
–0.252
0.083
–
–
–
0.15
0.035
–0.44
0.14
0.058
0.05
0.13
0.03
0.16
–0.22
–
0.03
0.17
–0.08
–0.664
–0.467
–0.433
–
–
0.34

1°
1°
1°
0.8°
0.95°
1°
1°
1°
1°
1.5°
1°
1°
1°
1°
1°
0.5°
0.5°

50
217
280
30
46
124
100
125
390
40
150
108
800
222
90
59
26
7
159
54
435
376
109
138
38
134
133
52
52
53
159
109
150
53
140
40
125
87
16
56

p

n.s.
<0.05
n.s.
n.s.
<0.05
n.s.
<0.01
<0.05
n.s.
<0.05
n.s.
0.17
<0.01
>0.05
–
<0.05
<0.1
–
–
–
–
n.s.
<0.01
–
–
n.s.
n.s.
n.s.
n.s.
n.s.
–
n.s.
<0.05
n.s.
<0.01
<0.01
<0.01
n.s.
n.s.
0.01

AF = Autofluorescence; HFP = heterochromatic flicker photometry; HPLC = high-performance liquid chromatography; RS = Raman spectroscopy; Ref. = reflectance.

Measurement of Macular Pigment Optical Density Using
Customized HFP in TILDA Subjects
MPOD was measured using the Macular Metrics Densitometer by HFP (Providence, R.l., USA). The device was modified
specifically for the TILDA trial from the one originally described
by Wooten et al. in 1999 [15]. Corrected distance visual acuity of

at least 6/18 was an inclusion criteria for MP measurement (note,
only one of the 79 subjects was excluded from testing based on this
requirement). The eye with better vision was chosen for measurement. Of the 79 subjects recruited into the pilot study, 64 subjects
were able to complete full MPOD assessment at 0.5° of eccentricity. Reasons for subjects not being able to complete full MPOD
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Table 2. Frequency settings used to estimate optimal HFP flicker
frequencies, by age, for both foveal and parafoveal measurements
when using the Densitometer

Age

Flicker frequency at 0.5° Flicker frequency at 7°

50–60
61–70
71–80
81+

14
13
12
11

9
8
7
6

assessment can be summarized as follows: too poor fixation, too
poor visual acuity, not able to follow instructions, and retinal pathology.
In order to measure MPOD, the subject views a stimulus that
alternates between a wavelength band absorbed by MP and one
that is not. The radiance of the wavelength band absorbed by MP
is adjusted in order to minimize the subjects’ perception of flicker. The range of alternation rates where flicker is not perceived is
called the null zone. Primarily because of inter-individual differences in temporal (e.g. flicker) sensitivity, it is optimal to customize the HFP task for each subject by selecting the alternation rate
to achieve a null zone and a precise setting. This has been termed
as customized HFP [16].
The first methodological consideration when using customized HFP is selecting the appropriate flicker rate. Selecting the
best flicker rate for each subject enables one to accommodate the
variation in flicker sensitivity due to factors such as age and disease [17, 18]. If differences among subjects in flicker sensitivity are
not accounted for (i.e. a fixed flicker frequency is used), then a
subject with low flicker sensitivity (i.e. low critical flicker fusion
frequency) will most likely experience a large null flicker zone.
Although the subject may be able to complete the task by eliminating flicker from the test target, the settings are likely to be variable, and subjects may exhibit systematic bias toward one end of
the null range, resulting in either over- or underestimation of
MPOD. Alternatively, a subject with a high critical flicker fusion
frequency may not be able to eliminate flicker from the test target,
which would make the task difficult to complete. Given that the
MP investigation part of the TILDA study is only one of many
parameters under investigation, we were aware of time constraints and therefore developed a ‘bracketing’ protocol (described below) to allow us to obtain quick, but accurate and customized, MPOD values. The sampling target used is a 1° diameter
disk with 5 min fixation point at the centre. The reference target
is a 2° diameter disk located 7° nasally with reference to a 5 min
red fixation point. The background is a 5° disk generated by a
light-emitting diode (460 nm with 20 nm half pass). Predicted
optimal HFP flicker frequencies were estimated in order to facilitate good subject performance and reduce measurement error.
To achieve this, we used an age-guided algorithm to estimate optimal HFP flicker frequencies for both the measurements performed (i.e. the measurement locus at 0.5° and reference locus at
7°; see below and table 2). This algorithm was informed by many
years’ experience with the Densitometer at several different laboratories. If the subject reports that there is no null flicker zone, the
flicker frequency is increased by 2 Hz and the examiner proceed-

4
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ed with macular pigment measurement. This step was repeated if
necessary.
The second methodological consideration involves a test stimulus configuration in which the radiances of the 2 alternating
components are inverse-yoked. In other words, when the blue
component is adjusted to be more intense, the luminance of the
green component is commensurately decreased, and vice versa.
This procedure keeps the brightness of the test stimulus relatively constant. This approach is regarded as an improvement because
some subjects find changes in brightness distracting when they
perform the task.
As mentioned above, the procedure used in the present study
has been termed as a ‘bracketing’ procedure and was developed
specifically for the TILDA investigation. This procedure was developed by members of the Macular Pigment Research Group,
Waterford, Ireland (J.M.N. and E.C.) and Prof. Wooten of Brown
University, USA (inventor of the Densitometer), and is described
below.
A description of the first part of the test (i.e. fovea, 0.5°) is
achieved using diagrams, to familiarize the subject with the task
ahead. The examiner selects the target required to measure
MPOD at 0.5° (i.e. 1° stimulus) using an accompanying standard
operating procedure developed for this device. The subject is instructed to place his/her test eye (the eye with best visual acuity,
or else their right eye if visual acuity is equal in both eyes) at the
viewing eyepiece and the investigator ensures that the tilt of the
main unit allows comfortable viewing for the subject. The appropriate flicker frequency is set for the subject’s age (table 2). The
examiner sets the radiance dial all the way to the left (i.e. lowest
blue light intensity). The examiner then pushes a button that electronically, smoothly and continuously alters the blue/green ratio
until the subject reports that there is no flicker. The radiance value obtained is recorded and this same procedure is repeated on 2
more occasions (3 in total) and recorded in the MPOD log form.
The examiner sets the radiance dial all the way to the right (i.e.
highest blue light intensity) and repeats the test 3 times as above.
Again, the radiance values obtained are recorded in the MPOD
log form. This completes the first part of the measurement (6 radiance values obtained in total, 3 approaching from the lowest
blue light intensity and 3 approaching from highest blue light intensity).
Then, a description of the second part of the measurement
(parafovea, 7°), using diagrams, is given to the subject by the
trained TILDA technician. The examiner selects the target and
fixation point required to measure MPOD at 7° using the accompanying standard operating procedure developed for this method
and the procedure is repeated for this target arrangement as described above for the 0.5° measurement. All radiance values obtained (12 in total) are then inputted into the MPOD calculator,
and an MPOD value at 0.5° is generated for that subject. It should
be noted that previous investigations into the spatial profile have
shown a secondary peak that occurs between 0.5° and 1° retinal
eccentricity in some subjects [19, 20]; however, it is important to
note that the value at 0.5° captures about 95% of the variance of
the entire MP distribution.
Previous models of the Densitometer (and most other similar
devices) control the blue/green energy ratio with a rotary knob.
Thus, the subject (if using self adjustment) or the experimenter (if
using bracketing) turn the knob until the desired point of noflicker is reached. This works well for most subjects. However,
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some are prone to adjust the knob much too slowly. Others, on the
other hand, make their adjustments too quickly. In the bracketing
procedure, there are individual differences in the way different
experimenters control the knob. The current version of the Densitometer avoids these potential sources of variability by substituting the knob with 2 push buttons: one button when depressed
and held down causes the blue/green ratio to increase, whereas the
other causes the blue/green ratio to decrease. Unlike a subject or
experimenter turning a knob, the rate of blue/green change is controlled entirely by the Densitometer’s electronics and was determined to be optimal (neither too fast or too slow) at 7 s for a sweep
from one extreme to the other of the blue/green ratio. Preliminary
studies have shown that this new procedure not only removes the
aforementioned variability, but the task is qualitatively easier for
the subjects.
Statistical Analysis
The statistical software package SPSS (version 15) was used for
statistical and graphical analysis. In addition, the software package Sigma plot (version 5) was used for some graphical analysis.
All variables investigated exhibited a typical normal distribution. Means 8 SDs are presented in the text. Pearson correlation
coefficients were calculated to investigate bivariate relationships.
The significance between group differences was determined by
1-way ANOVA or independent samples t test, depending on the
analysis in question. We used the 5% level of significance throughout our analysis.

Results

Demographics and Variables of Relevance to AMD
The mean 8 SD age of the 79 subjects recruited into
the TILDA pilot I study was 65 8 11 years. Twenty-nine
of the subjects were male and 50 were female. The mean
8 SD BMI of the study group was 28 8 6. Of the 72 subjects that reported their smoking habits, 39 reported that
they smoked cigarettes, cigars, cigarillos or a pipe daily
for a period of at least 1 year during their lifetime, and 33
subjects reported that they had not. Of the 70 subjects
that reported presence or absence of a family history of
AMD in a first degree relative (i.e. parent or sibling), 9
(12.9%) reported a positive family history of AMD,
whereas 61 (87.1%) reported no known family history of
AMD. The mean 8 SD MPOD at 0.5° of eccentricity for
the TILDA pilot I study group was 0.23 8 0.17.
AMD Prevalence in Study Group
Undilated retinal fundus photographs were obtained
(non-mydriatic NIDEK NM100 Type D camera) on both
eyes of all subjects recruited into the study. Of the 158
eyes photographed, 123 pictures were deemed of sufficient quality for retinological assessment with respect to
the presence or absence of AMD by a retinologist (S.B.).
Macular Pigment Optical Density in an
Ageing Irish Population
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It is perhaps unsurprising that 22% of photographs were
of insufficient quality, given the impact of age-related miosis and lens opacity on a study population with this age
profile, and given that this was a pilot study. Of the 123
eyes suitable for assessment, 29 eyes (24%) exhibited signs
of early AMD (i.e. soft drusen, hyper- and/or hypo-pigmentary changes). In terms of subjects, 17 (28%) of the 61
subjects whose photographs were suitable for grading had
evidence of early disease (as above), with bilateral disease
evident in 12 (70%) of these subjects. Of the photographs
upon which comment could be reliably made, no eyes exhibited signs of advanced AMD.
The large percentage (22%) of retinal photographs that
were deemed of insufficient quality for retinal assessment
in this pilot was an important learning outcome from the
study. Indeed, the TILDA research teams have now taken
appropriate measures to address this issue. For example,
collaboration between the Retinal Reading Center, University of Wisconsin, and the TILDA research team has
now been established, and will include: quality control of
AMD grading and implementation of standard operating
procedures and training and certifying the TILDA nurses (to optimize the number of ‘gradable images’ compared to the results presented here).
MPOD with Respect to Variables Relevant to AMD
MPOD and Age
There was a moderate, but statistically significant,
age-related decline in MPOD at 0.5° (r = –0.251, p = 0.045;
fig. 1). Also, using a normative database of an additional
462 subjects, aged between 18 and 67 years (data previously collected and archived by the MPRG using the same
measuring device as that used in this study) allowed for
further, and more detailed (greater age spread for comparison), investigation of the relationship between MPOD
and age. Upon merging the databases, the significant inverse relationship between age and MPOD remained
(r = –0.179, p = 0.000; fig. 2).
Reporting the data in terms of MPOD change per age
decade, we see a significant stepwise reduction in MPOD
(ANOVA; p = 0.000; fig. 3).
MPOD and Cigarette Smoking
The 39 subjects who reported that they smoked cigarettes, cigars, cigarillos or a pipe daily for a period of at
least 1 year during their lifetime had significantly lower
average MPOD values when compared to the 33 subjects
who reported that they had not (mean 8 SD MPOD at
0.5° = 0.18 8 0.14 and 0.28 8 0.19, respectively; fig. 4).
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0.8
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0.6
MPOD (0.5°)

MPOD (0.5°)
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0
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Age (years)
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20

90

Fig. 1. Age-related decline in MPOD for TILDA subjects (n = 64).
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Age (years)
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Fig. 2. Age-related decline in MPOD for 521 Irish subjects.

0.6
0.5
0.60

MPOD (0.5°)

MPOD (0.5°)

0.4
0.3
0.2

0.40

0.20
0.1
0

0
18–30

31–40

41–50 51–60
Age (years)

61–70

71+

Fig. 3. Age-related decline in MPOD for 521 subjects (per decade).

Smokers

Non-smokers

Fig. 4. MPOD and smoking habits.

Values presented = mean 8 SD MPOD (per decade).

MPOD and Sex
Females had significantly higher MPOD values when
compared to their male counterparts (mean 8 SD MPOD
at 0.5° = 0.27 8 0.17 and 0.18 8 0.15, respectively, p =
0.032).
MPOD and BMI
There was no significant relationship found between
MPOD and BMI in the TILDA study group (r = –0.26,
p = 0.836).
6
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MPOD and Its Relationship with Risk Factors for
AMD as Assessed by Multiple Linear Regression
Analysis
Multiple linear regression analysis was performed to
analyze the relationship between MPOD and the following known and suggested risk factors for AMD: age; sex;
smoking habits; family history of early AMD, and BMI.
Statistically non-significant variables were then removed,
one by one, using the 5% level of significance as the criterion for removal. The regression model eventually obNolan /Kenny /O’Regan /Cronin /
Loughman /Conolly /Kearney /Beatty

11.03.2010 14:54:34

MPOD (0.5°)

0.60

0.40

0.20

0
Subjects with
no signs of AMD

Subjects with
signs of early AMD

Fig. 5. MPOD in subjects with and without early stage AMD.

tained explains about 11% of the variation in MP, with the
variable age and smoking habits remaining significant
independent predictors of MP (p ! 0.05, for both).
MPOD with Respect to Early AMD Prevalence
Both MPOD measurement and retinal assessment
were successfully completed in 64 of the 79 subjects recruited into the study. Twelve of the 17 (70%) subjects
with early AMD were able to complete the test for MPOD
measurement, whereas 52 of the 62 (84%) subjects with
no signs of AMD were able to complete the test for MPOD
measurement. Mean 8 SD MPOD in subjects with no
signs of AMD was significantly higher when compared
to subjects with early stage AMD (mean MPOD at 0.5° =
0.25 8 0.17 and 0.14 8 0.13, respectively; fig. 5).

Discussion

TILDA represents a unique opportunity to investigate
the prevalence and incidence of AMD, as well as the risk
factors for and impact of this condition in a longitudinal
fashion, in a naturally representative sample of at least
8,000 participants.
This pilot study reports on MPOD in an ageing randomly selected sample of the Irish population (TILDA
pilot phase I). Mean MPOD in this ageing adult populaMacular Pigment Optical Density in an
Ageing Irish Population
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tion was 0.23, which is low when compared to different
study populations across all ages (18–87, years inclusive)
[13, 21–25]. Although optimal MP values have yet to be
established, there is a growing body of evidence in support of the view that MP protects against AMD via its
antioxidant and short-wavelength filtering properties
[10, 26, 27]. This evidence is primarily available from observational and supplementation studies [13, 28–35]. For
a critical review of the scientific literature on this topic,
see the recent publication by Loane et al. in 2008 [26].
There are numerous risk factors for AMD, and it has
been established that age, cigarette smoking and a family
history of AMD are the most important and undisputed.
Of the risk factors that were investigated in the TILDA
pilot study, increasing age and smoking habits (2 of the 3
established risk factors for AMD) were independently,
and significantly, associated with a relative lack of MP. No
meaningful comment can be made with regards to family history of AMD, as this data was self-reported and is
therefore of limited value, especially when one considers
that all subjects enrolled were 150 years of age and therefore their parents probably did not enjoy the longevity
seen today and associated with the current epidemic of
AMD.
The age-related decline in MPOD and the relative lack
of MP in association with tobacco use are consistent with
previous findings by our research group, and are in support of the hypothesis that a relative lack of MP is associated with risk for AMD [13], but are not in agreement
with data reported from the ‘Carotenoids in Age-Related
Eye Disease Study – CAREDS’ investigation which measured MPOD in 1,698 women aged 53–86 years [36]. Possible explanations for the outcome discrepancies between
these studies may be differences in the sample populations studied, the fact that CAREDS included female subjects only, and differences in dietary and lifestyle habits
between the populations studied.
The age-related decline in MPOD observed here represents an association between the most universal risk
factor for AMD and a relative lack of the macular carotenoids, and is consistent with the view that the increasing
vulnerability of the ageing macula to AMD may be attributable, at least in part, to a parallel and age-related
decline in the optical density of MP at the central retina.
The observed age-related drop in MP may be attributable
to excessive depletion, or inadequate uptake, of the macular carotenoids in association with increasing age. A depletion of MP with age would be consistent with excessive
utilization of the macular carotenoids in response to the
age-related increase in oxidant load, but could also be atOphthalmic Res 976
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tributable to age-related changes in dietary intake, absorption, transport in serum, and/or capture by retinal
tissue of these carotenoids [13, 37, 38].
It should be emphasized that our observations are associative only, as are all the published data investigating
the relationship between age and MPOD. Indeed, addressing this issue by analysing serial MPOD measurements in subjects over time is a key goal of the collaborative research between the MPRG and TILDA, and the
subject of future work. Nevertheless, the data presented
here represent the first analysis of MPOD values in subjects randomly selected according to best practice in
terms of epidemiologic study design, where a validated
technique (refined for elderly subjects) of measuring the
optical density of MP was used, and where a large normative database of MP values (assessed using the same technique) of a similar but younger Irish population was readily available for comparison.
Not only do the TILDA pilot data exhibit an age-related decline in MPOD in subjects over 50 years, the observed and modest, but statistically significant, age-related decline in MPOD remained when we merged the data
with a larger database with a wider age spread (n = 541,
aged 18–89 years in total, additional data collected by the
MPRG using the same measuring device as the one used
in this study). Indeed, comparing the oldest age group
available (aged 70 years or more) to the youngest age
group available (aged 18–30 years), we see a mean differ-

ence in MPOD of 0.23 optical density units (p = 0.000). It
is also important to note that, while the literature is conflicting with respect to the relationship between age and
MP (table 1), of the 17 published studies that used HFP to
measure MPOD and report on its association with age, 10
report an age-related decline in MPOD (7 of which were
statistically significant), 6 report no age effect in MPOD,
and only 1 study reported an age-related increase in
MPOD.
Other interesting observations, which have emanated
from this pilot study, include the prevalence of early
AMD (28%) in a randomly selected sample of Irish subjects over 50 years of age and the statistically significant
relative lack of MP seen in subjects who displayed early
signs of AMD. This latter finding is consistent with a previous report by Beatty et al. [39] and is also consistent
with the hypothesis that a relative lack of MP is associated with disease. However, and again, this observation
remains associative only, and causality cannot be inferred.
In conclusion, we report an association between declining MPOD and increasing age. Ultimately, however,
longitudinal data in a larger cohort of participants are
required to satisfactorily investigate the relationship
between the optical density of this pigment and age,
and with risk for development and/or progression of
AMD. This pilot study represents a first step in this endeavour.
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